Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, L. H.
Right arrow Articles by Panicek, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, L. H.
Right arrow Articles by Panicek, D. M.
Clinical Cancer Research Vol. 9, 4318-4323, October 1, 2003
© 2003 American Association for Cancer Research


Clinical Trials

Variability in Response Assessment in Solid Tumors

Effect of Number of Lesions Chosen for Measurement

Lawrence H. Schwartz1, Madhu Mazumdar, Wendy Brown, Alex Smith and David M. Panicek

Departments of Radiology [L. H. S., W. B., D. M. P.] and Epidemiology and Biostatistics [M. M., A. S.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021, and Weill Medical College of Cornell University, New York, New York [L. H. S., M. M., D. M. P.]

ABSTRACT

Purpose: This study was performed to systematically evaluate the variability in tumor response assessments that occurs depending on how many tumor deposits are selected for measurement at imaging.

Experimental Design: The two largest perpendicular diameters of all tumor deposits in 36 patients were measured on computed tomography scans obtained at baseline and first posttherapy follow-up. A computerized modeling analysis of those data was performed to determine each patient’s therapeutic response category assignment for every possible number of lesions in a grouping. The variance in the sum of measurements of these lesion groupings was calculated, and the frequency of response assessment categories was plotted against the number of lesions.

Results: The computerized analysis of the resultant 1,833,821 possible combinations of tumor deposits showed that when six lesions were measured bidimensionally and four lesions were measured undimensionally, the average variance decreased by 90%. The number of different response assessment categories into which a patient was assigned decreased with increasing lesion grouping size. When six or more lesions were measured bidimensionally, 9% of all possible lesion groupings still fell into a second response category, reflecting the effect of which particular lesions are chosen for measurement.

Conclusions: Measuring larger numbers of lesions will decrease the variance. In this population, the variance decreased by at least 90% when six or more lesions were measured bidimensionally. Further confirmatory studies with larger series of patients are warranted before adopting this number as a criterion in clinical trials for assessing the activity of antineoplastic therapies.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
C. Suzuki, H. Jacobsson, T. Hatschek, M. R. Torkzad, K. Boden, Y. Eriksson-Alm, E. Berg, H. Fujii, A. Kubo, and L. Blomqvist
Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations
RadioGraphics, March 1, 2008; 28(2): 329 - 344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. H. Schwartz, D. M. Panicek, and M. Mazumdar
Measuring hepatic metastases to colon cancer.
Am. J. Roentgenol., November 1, 2006; 187(5): W552 - W552.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. T. Zacharia, S. Saini, E. F. Halpern, and J. E. Sumner
CT of Colon Cancer Metastases to the Liver Using Modified RECIST Criteria: Determining the Ideal Number of Target Lesions to Measure.
Am. J. Roentgenol., April 1, 2006; 186(4): 1067 - 1070.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.